| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.14 | 0.001 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.001 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.001 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | 0.15 | 0.001 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.001 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |